Skip to main content
Sinisa Dovat, MD, Pediatric Hematology & Oncology, Hershey, PA

SinisaDovatMD

Pediatric Hematology & Oncology • Hershey, PA

Professor, Pediatrics, Pennsylvania State University College of Medicine

Join to view full profile

Dr. Dovat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dovat's full profile

Already have an account?

  • Office

    500 University Dr
    Hershey, PA 17033
    Phone+1 800-243-1455
    Fax+1 608-263-0440

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1993 - 1996
  • University of Novi Sad Faculty of Medicine
    University of Novi Sad Faculty of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1996 - Present
  • PA State Medical License
    PA State Medical License 1994 - 2026
  • WI State Medical License
    WI State Medical License 2004 - 2021
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • CK2 Inhibitor CX4945 Shows Strong In Vivo Synergistic Anti-Leukemia Activity with Rapamycin in B-ALL Due to Enhanced Ikaros Mediated Repression of mTOR Pathway
    Sinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • CK2 Inhibitor CX4945 Shows Strong In Vivo Anti Leukemia Effect in AML Via Augmented Ikaros-Mediated Regulation of Global Epigenetic Landscape
    Sinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Oncogenesis of CRLF2 Overexpression and Effect of JAK2 Inhibitor in CRLF2 Overexpressed B-Cell Acute Lymphoblastic Leukemia
    Sinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • The Novel Small Molecule Inhibitor KS99 Targets AML and Inhibits Stemness Markers STAT3 and ALDH 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology Research
    College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology ResearchSeptember 25th, 2024
  • Increased Incidence of IKZF1 Deletions and IGH-CRLF2 Translocations in B-ALL of Hispanic/Latino Children—a Novel Health Disparity
    Increased Incidence of IKZF1 Deletions and IGH-CRLF2 Translocations in B-ALL of Hispanic/Latino Children—a Novel Health DisparityFebruary 2nd, 2021
  • Genetic Variants Could Explain High Leukemia Rates in Hispanic Children
    Genetic Variants Could Explain High Leukemia Rates in Hispanic ChildrenFebruary 2nd, 2021
  • Join now to see all

Grant Support

  • The Role Of Zinc Finger Genes In LeukemogenesisNational Heart, Lung, And Blood Institute2010–2011
  • The Role Of Zinc Finger Genes In LeukemogenesisNational Heart, Lung, And Blood Institute2009–2010
  • The Role Of Zinc Finger Genes In Cellular ProliferationNational Cancer Institute2005–2007
  • The Role Of Zinc Finger Genes In HematopoiesisNational Cancer Institute2003
  • The Role Of Zinc Finger Genes In HematopoiesisNational Cancer Institute1999–2003

Dr. Sinisa Dovat, Dr. Sinisa Dovat, MD, Dr. S Dovat